This week, a 40-year-old patient was treated at UNC’s Clinical and Translational Research Center (CTRC) with SB-913, an investigational genome editing therapy for individuals with mucopolysaccharidosis type II (MPS II), a rare lysosomal storage disorder also known as Hunter syndrome. Read more >>
Dr. Wesley Burks was featured in an ABC News story about peanut immunotherapy after the publication of a recent study he co-authored in the Journal of Allergy and Clinical Immunology: In Practice. Read more >>
In addition to our regular CRI Activities Update, this month’s Research Focus highlights collaborative work from the team led by Aravinda de Silva, PhD, MPH, Professor of Microbiology and Immunology and a member of the UNC Institute for Global Health and Infectious Diseases. Activities Update: We held our Medical Foundation Board of Visitors meeting on February … Read more
In addition to our regular CRI Activities Update, this month’s Research Focus highlights collaborative work from the team led by Joseph Muenzer, MD, PhD, Professor of Pediatric and Genetics. Activities Update: This past month we have been busy with research grants. We had a Creativity Hub submission to the UNC Office of the Vice Chancellor for … Read more
UNC School of Medicine scientists show that therapies to break up mucus in toddlers might offer the best route to a longer life for CF patients. Read more >>